FULPHILA

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, New Zealand, Poland, Romania, United States

Active ingredients

The drug FULPHILA contains one active pharmaceutical ingredient (API):

1 Pegfilgrastim UNII 3A58010674 - PEGFILGRASTIM

Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Pegfilgrastim and filgrastim have been shown to have identical modes of action, causing a marked increase in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes and/or lymphocytes. Read about Pegfilgrastim

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FULPHILA Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AA13	Pegfilgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6363X, 9514R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541521010018407
Country: CA	Health Products and Food Branch	Identifier(s): 02484153
Country: EE	Ravimiamet	Identifier(s): 1783076
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 107460
Country: FR	Base de données publique des médicaments	Identifier(s): 60457929
Country: HK	Department of Health Drug Office	Identifier(s): 66770
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8639
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086597, 1086599
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20523
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100416507
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65788001, W65788002
Country: US	FDA, National Drug Code	Identifier(s): 67457-833